Brachytherapy is a possible treatment for localized low risk prostate cancer.
Although this option is minimally invasive, some side effects may occur. Acute retention of urine (ARU) has been observed in 5% to 22% of cases and can be prevented in most cases by alpha-blocker treatment. Several alternatives have been reported in the literature for the management of ARU following brachytherapy: prolonged suprapubic catheterization, transurethral resection of the prostate and also intermittent self-catheterization. The authors report an original endoscopic approach, using urethral endoprosthesis, with a satisfactory voiding status.
Written by:
Kerkeni W, Chahwan C, Lenormand C, Dubray B, Benyoucef A, Pfister C. Are you the author?
Service d'urologie, CHU de Rouen, 1, rue de Germont, 76031 Rouen cedex, France; Service de radiothérapie, Institut Henri-Becquerel, rue d'Amiens, 76000 Rouen, France.
Reference: Prog Urol. 2014 Mar;24(3):164-6.
doi: 10.1016/j.purol.2013.07.013
PubMed Abstract
PMID: 24560204
Article in French.
UroToday.com Prostate Cancer Section
